Upgrade to SI Premium - Free Trial

Leerink Partners Remains Bullish on Zimmer Biomet Holdings (ZBH) Following an In-Line 3Q

October 30, 2015 11:54 AM
Leerink Partners maintained an Outperform rating on Zimmer Holdings (NYSE: ZBH), and cut the price target to $125.00 (from $130.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles